Read + Share
Blackmon AL, Hourigan CS. Test then erase? Current status and future opportunities for Measurable Residual
Disease testing in Acute Myeloid Leukemia. Acta Haematol 2023 Nov 30. doi: 10.1159/000535463.
PMID: 38035547
|
 |
|
Blackmon AL, Hourigan CS. Test then erase? Current status and future opportunities for Measurable Residual
Disease testing in Acute Myeloid Leukemia. Acta Haematol 2023 Nov 30. doi: 10.1159/000535463.
PMID: 38035547
|
|
|
|